Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication October 10, 2017
- Accepted for publication December 6, 2017
- Published online June 5, 2018.
Article Versions
- previous version (February 2, 2018 - 12:53).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Nicholas Keat1,
- Julia Kenny2,
- Keguan Chen3,
- Mayca Onega1,
- Nadia Garman4,
- Robert J. Slack5,
- Christine A. Parker6,
- R. Thomas Lumbers5,
- Will Hallett1,
- Azeem Saleem1,
- Jan Passchier1 and
- Pauline T. Lukey5
- 1Imanova Ltd., London, United Kingdom
- 2In Vitro In Vivo Translation, GlaxoSmithKline R&D, Ware, United Kingdom
- 3Immunogenicity and Clinical Immunology, GlaxoSmithKline R&D, Upper Merion, Pennsylvania
- 4Clinical Operations, GlaxoSmithKline R&D, Stevenage, United Kingdom
- 5Fibrosis Discovery Performance Unit, GlaxoSmithKline R&D, Stevenage, United Kingdom; and
- 6Clinical Imaging, GlaxoSmithKline R&D, Stevenage, United Kingdom
- For correspondence or reprints contact: Pauline T. Lukey, Fibrosis Discovery Performance Unit, GlaxoSmithKline R&D, Gunnels Wood Rd., Stevenage SG1 2NY, U.K. E-mail: pauline.t.lukey{at}gsk.com